Jump to Navigation
Trends and Sentiments
Comments and Analysis
Reading the bond market tea leaves
Briefing: Hasbro Outperforms Mattel as Barbie’s Struggles...
Itineraries: Love Field Flight Limits End, and Passengers...
Frequent Flier: A Wayward Tablet Shares a Seat Pocket...
M&A Deals Fail At Highest Rate Since 2008
Medicaid: Two Years Late, John Kasich Gets Religion: Live...
AbbVie says $55 billion acquisition of Shire officially...
UPS says U.S. rates to rise 4.9 percent as of December 29
Apple's iPhone sales beat Street but iPad volumes...
Bits Blog: Amazon Strikes Deal With Simon & Schuster
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
Could Sears’ real estate deal with U.K.’s Primark...
The Tragedy Of NATO: "Beware Foreign...
EUR/GBP: 1.2629 USD/EUR: 1.2795 JPY/USD: 106.908
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions